• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p84与p110γ形成负调控复合物,以在细胞迁移过程中控制PI3Kγ信号传导。

p84 forms a negative regulatory complex with p110γ to control PI3Kγ signalling during cell migration.

作者信息

Turvey Michelle E, Klingler-Hoffmann Manuela, Hoffmann Peter, McColl Shaun R

机构信息

Chemokine Biology Laboratory, School of Molecular and Biomedical Sciences, The University of Adelaide and Centre for Molecular Pathology, Adelaide, South Australia, Australia.

Adelaide Proteomics Centre, The University of Adelaide, Adelaide, South Australia, Australia.

出版信息

Immunol Cell Biol. 2015 Sep;93(8):735-43. doi: 10.1038/icb.2015.35. Epub 2015 Mar 10.

DOI:10.1038/icb.2015.35
PMID:25753393
Abstract

Phosphoinositide 3-kinase γ (PI3Kγ) consists of the catalytic subunit p110γ that forms a mutually exclusive heterodimer with one of the two adaptor subunits, p101 or p84. Although activation of PI3Kγ is necessary for cell migration downstream of G-protein-coupled receptor engagement, particularly within the immune system, aberrant PI3Kγ signalling has been associated with transformation, increased migration and the progression of multiple cancer types. Regulation of PI3Kγ signal activation and duration is critical to controlling and maintaining coordinated cellular migration; however, the mechanistic basis for this is not well understood. We have recently demonstrated that, in contrast to the tumour-promoting potential of p110γ and p101, p84 possesses tumour-suppressor activity, suggesting a negative regulatory role within PI3Kγ signalling. The present study investigated the role of p84 phosphorylation in the context of PI3Kγ signalling, cell migration and p84-mediated tumour suppression. Two putative phosphorylation sites were characterised within p84, Ser358 and Thr607. Expression of wild-type p84 reduced the oncogenic potential of MDA.MB.231 cells and inhibited metastatic lung colonisation in vivo, effects that were dependent on Thr607. Furthermore, loss of Thr607 enhanced migration of MDA.MB.231 cells in vitro and prevented the induction of p84/p110γ dimers. The dimerisation of wild-type p84 with p110γ was not detected at the plasma membrane, indicating an inhibitory interaction preventing PI3Kγ lipid-kinase activity. In contrast, Ser358 phosphorylation was not determined to be critical for p84 activity in the context of migration. Our findings suggest that p84 binding to p110γ may represent a novel negative feedback signal that terminates PI3Kγ activity.

摘要

磷酸肌醇3激酶γ(PI3Kγ)由催化亚基p110γ组成,该亚基与两个衔接子亚基之一p101或p84形成互斥异二聚体。尽管PI3Kγ的激活对于G蛋白偶联受体激活下游的细胞迁移是必需的,尤其是在免疫系统中,但异常的PI3Kγ信号传导与多种癌症类型的转化、迁移增加和进展有关。PI3Kγ信号激活和持续时间的调节对于控制和维持协调的细胞迁移至关重要;然而,对此的机制基础尚不清楚。我们最近证明,与p110γ和p101的促肿瘤潜力相反,p84具有肿瘤抑制活性,提示其在PI3Kγ信号传导中起负调节作用。本研究在PI3Kγ信号传导、细胞迁移和p84介导的肿瘤抑制背景下研究了p84磷酸化的作用。在p84内鉴定出两个假定的磷酸化位点,即Ser358和Thr607。野生型p84的表达降低了MDA.MB.231细胞的致癌潜力,并在体内抑制了转移性肺定植,这些作用依赖于Thr607。此外,Thr607的缺失增强了MDA.MB.231细胞在体外的迁移,并阻止了p84/p110γ二聚体的诱导。未在质膜检测到野生型p84与p110γ的二聚化,表明存在抑制性相互作用,阻止PI3Kγ脂质激酶活性。相反,在迁移背景下,Ser358磷酸化对p84活性并不关键。我们的研究结果表明,p84与p110γ的结合可能代表一种新型负反馈信号,可终止PI3Kγ活性。

相似文献

1
p84 forms a negative regulatory complex with p110γ to control PI3Kγ signalling during cell migration.p84与p110γ形成负调控复合物,以在细胞迁移过程中控制PI3Kγ信号传导。
Immunol Cell Biol. 2015 Sep;93(8):735-43. doi: 10.1038/icb.2015.35. Epub 2015 Mar 10.
2
Differential roles for the p101 and p84 regulatory subunits of PI3Kγ in tumor growth and metastasis.PI3Kγ 的 p101 和 p84 调节亚基在肿瘤生长和转移中的差异作用。
Oncogene. 2012 May 3;31(18):2350-61. doi: 10.1038/onc.2011.414. Epub 2011 Sep 26.
3
PI3Kgamma adaptor subunits define coupling to degranulation and cell motility by distinct PtdIns(3,4,5)P3 pools in mast cells.PI3Kγ衔接亚基通过肥大细胞中不同的磷脂酰肌醇-3,4,5-三磷酸(PtdIns(3,4,5)P3)池来定义与脱颗粒和细胞运动的偶联。
Sci Signal. 2009 Jun 9;2(74):ra27. doi: 10.1126/scisignal.2000259.
4
Gβγ is a direct regulator of endogenous p101/p110γ and p84/p110γ PI3Kγ complexes in mouse neutrophils.Gβγ是小鼠中性粒细胞内源性p101/p110γ和p84/p110γ PI3Kγ复合物的直接调节因子。
Sci Signal. 2020 Nov 3;13(656):eaaz4003. doi: 10.1126/scisignal.aaz4003.
5
The regulatory subunits of PI3Kγ control distinct neutrophil responses.PI3Kγ的调节亚基控制不同的中性粒细胞反应。
Sci Signal. 2015 Jan 20;8(360):ra8. doi: 10.1126/scisignal.2005564.
6
PI3K Regulatory Protein p84 Determines Mast Cell Sensitivity to Ras Inhibition-Moving Towards Cell Specific PI3K Targeting?PI3K 调节蛋白 p84 决定肥大细胞对 Ras 抑制的敏感性——向细胞特异性 PI3K 靶向迈进?
Front Immunol. 2020 Oct 28;11:585070. doi: 10.3389/fimmu.2020.585070. eCollection 2020.
7
PKCβ phosphorylates PI3Kγ to activate it and release it from GPCR control.PKCβ 使 PI3Kγ 磷酸化以使其激活并使其脱离 GPCR 的控制。
PLoS Biol. 2013;11(6):e1001587. doi: 10.1371/journal.pbio.1001587. Epub 2013 Jun 25.
8
p84, a new Gbetagamma-activated regulatory subunit of the type IB phosphoinositide 3-kinase p110gamma.p84,一种新型的由Gβγ激活的I型磷酸肌醇3激酶p110γ调节亚基。
Curr Biol. 2005 Mar 29;15(6):566-70. doi: 10.1016/j.cub.2005.02.020.
9
Different inhibition of Gβγ-stimulated class IB phosphoinositide 3-kinase (PI3K) variants by a monoclonal antibody. Specific function of p101 as a Gβγ-dependent regulator of PI3Kγ enzymatic activity.单克隆抗体对Gβγ刺激的IB类磷酸肌醇3激酶(PI3K)变体的不同抑制作用。p101作为PI3Kγ酶活性的Gβγ依赖性调节剂的特定功能。
Biochem J. 2015 Jul 1;469(1):59-69. doi: 10.1042/BJ20150099.
10
Molecular determinants of PI3Kγ-mediated activation downstream of G-protein-coupled receptors (GPCRs).PI3Kγ 介导的 G 蛋白偶联受体(GPCRs)下游激活的分子决定因素。
Proc Natl Acad Sci U S A. 2013 Nov 19;110(47):18862-7. doi: 10.1073/pnas.1304801110. Epub 2013 Nov 4.

引用本文的文献

1
Multi-omics approach identifies germline regulatory variants associated with hematopoietic malignancies in retriever dog breeds.多组学方法鉴定与猎犬品种血液系统恶性肿瘤相关的种系调控变异。
PLoS Genet. 2021 May 13;17(5):e1009543. doi: 10.1371/journal.pgen.1009543. eCollection 2021 May.
2
Function, Regulation and Biological Roles of PI3Kγ Variants.PI3Kγ 变异体的功能、调节和生物学作用。
Biomolecules. 2019 Aug 30;9(9):427. doi: 10.3390/biom9090427.
3
Distinct roles for phosphoinositide 3-kinases γ and δ in malignant B cell migration.

本文引用的文献

1
The atypical chemokine receptor CCX-CKR regulates metastasis of mammary carcinoma via an effect on EMT.非典型趋化因子受体CCX-CKR通过对上皮-间质转化的影响来调控乳腺癌转移。
Immunol Cell Biol. 2014 Nov;92(10):815-24. doi: 10.1038/icb.2014.58. Epub 2014 Jul 15.
2
Molecular determinants of PI3Kγ-mediated activation downstream of G-protein-coupled receptors (GPCRs).PI3Kγ 介导的 G 蛋白偶联受体(GPCRs)下游激活的分子决定因素。
Proc Natl Acad Sci U S A. 2013 Nov 19;110(47):18862-7. doi: 10.1073/pnas.1304801110. Epub 2013 Nov 4.
3
PI3Kγ kinase activity is required for optimal T-cell activation and differentiation.
PI3Kγ 和 PI3Kδ 在恶性 B 细胞迁移中发挥不同作用。
Leukemia. 2018 Sep;32(9):1958-1969. doi: 10.1038/s41375-018-0012-5. Epub 2018 Jan 31.
PI3Kγ 激酶活性对于 T 细胞的最佳激活和分化是必需的。
Eur J Immunol. 2013 Dec;43(12):3183-96. doi: 10.1002/eji.201343812. Epub 2013 Oct 9.
4
p87 and p101 subunits are distinct regulators determining class IB phosphoinositide 3-kinase (PI3K) specificity.p87 和 p101 亚基是决定 I 类磷肌醇 3-激酶 (PI3K) 特异性的独特调节因子。
J Biol Chem. 2013 Oct 25;288(43):31059-68. doi: 10.1074/jbc.M113.508234. Epub 2013 Sep 6.
5
PKCβ phosphorylates PI3Kγ to activate it and release it from GPCR control.PKCβ 使 PI3Kγ 磷酸化以使其激活并使其脱离 GPCR 的控制。
PLoS Biol. 2013;11(6):e1001587. doi: 10.1371/journal.pbio.1001587. Epub 2013 Jun 25.
6
Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.利用 cBioPortal 进行复杂癌症基因组学和临床特征的综合分析
Sci Signal. 2013 Apr 2;6(269):pl1. doi: 10.1126/scisignal.2004088.
7
G protein-coupled receptor-mediated activation of p110β by Gβγ is required for cellular transformation and invasiveness.G 蛋白偶联受体介导的 Gβγ 对 p110β 的激活对于细胞转化和侵袭性是必需的。
Sci Signal. 2012 Dec 4;5(253):ra89. doi: 10.1126/scisignal.2003264.
8
The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.cBio 癌症基因组学门户:一个用于探索多维癌症基因组学数据的开放平台。
Cancer Discov. 2012 May;2(5):401-4. doi: 10.1158/2159-8290.CD-12-0095.
9
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.2000 个乳腺肿瘤的基因组和转录组结构揭示了新的亚群。
Nature. 2012 Apr 18;486(7403):346-52. doi: 10.1038/nature10983.
10
Targeting nonclassical oncogenes for therapy in T-ALL.针对 T-ALL 中的非典型癌基因进行治疗。
Cancer Cell. 2012 Apr 17;21(4):459-72. doi: 10.1016/j.ccr.2012.02.029.